Infliximab therapy in pediatric Takayasu's arteritis: Report of two cases

Research output: Contribution to journalArticlepeer-review


Takayasu arteritis (TA) is a chronic vasculitis of unknown etiology. Experience with anti-tumor necrosis factor alpha (anti-TNF) agents in difficult-to-treat patients with TA is limited and refers to adult patients. Here, we present two cases of pediatric TA treated with infliximab, in which clinical remission was observed. Anti-TNF treatment represents a useful therapy in pediatric Takayasu arteritis too, especially to avoid the risk of long-term corticosteroids toxicity.

Original languageEnglish
Pages (from-to)93-95
Number of pages3
JournalRheumatology International
Issue number1
Publication statusPublished - Jan 2011


  • Arteritis
  • Biologic agents
  • Pediatric
  • Vasculitis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'Infliximab therapy in pediatric Takayasu's arteritis: Report of two cases'. Together they form a unique fingerprint.

Cite this